|
|
||||||||
1 From the Jules Stein Eye Institute and Departments of Ophthalmology, and 2 Pathology and Laboratory Medicine, University of California Los Angeles School of Medicine.
| Abstract |
|---|
|
|
|---|
METHODS. Experimental and control rat eyes were injected with 80 colony-forming units of viable S. aureus and lipopolysaccharide-free sterile saline (NS), respectively. Eyes were enucleated and immediately frozen. E-selectin and ICAM-1 expression were evaluated on frozen sections by using standard immunohistochemical techniques. Using an enzyme-linked immunoassay, in vitro expression of E-selectin and ICAM-1 was evaluated on macrovascular endothelial cells after stimulation with S. aureus and selected purified components.
RESULTS. In S. aureusinjected eyes, E-selectin and ICAM-1 expression peaked at six to 24 hours, decreased slightly at 24 and 48 hours, and further declined by 72 hours. However, in NS-injected eyes, peak levels of E-selectin and ICAM-1 were seen at 6 hours, after which expression declined in the areas in which an increase was previously observed. In in vitro assays, peptidoglycan (0.01 µg/ml) induced a fourfold increase in E-selectin (P < 0.0001) and a twofold increase in ICAM-1 (P < 0.002) expression. Ribitol teichoic acid (RTA) (1 µg/ml) induced a twofold increase in E-selectin (P < 0.0001) and a threefold increase in ICAM-1 (P < 0.0001) expression.
CONCLUSIONS. Eyes injected with S. aureus demonstrated a more intense and prolonged expression of both E-selectin and ICAM-1 than did eyes injected with NS. In addition, S. aureus components induced the in vitro expression of these adhesion molecules on macrovascular endothelial cells. The relevance of these findings to microvascular endothelial cells is yet to be determined.
| Introduction |
|---|
|
|
|---|
The interaction of leukocytes with vascular endothelial cells represents a key control point in normal lymphocyte recirculation and leukocyte recruitment during inflammatory responses. The process of leukocyte recruitment into an area of inflammation follows a three-step paradigm.9 It begins with the margination of inflammatory cells to the slower flow of the peripheral blood column. Leukocytes loosely adhere to endothelial cells, and that induces rolling of the inflammatory cell along the vessels luminal surface. This "rolling" process is mediated by sialyated Lewis X moieties on leukocytes and by adhesion molecules called selectins on endothelial cells.10 11 E-selectin is a major endothelial ligand mediating the entry of neutrophils,12 the predominant infiltrating inflammatory cell population in acute bacterial infections. After binding to selectins, inflammatory cells sample the local environment, and if the appropriate signals are present, activation of the leukocyte occurs, resulting in firm adhesion to the endothelial cell. After this process, leukocytes transmigrate between endothelial cells into tissue. One important mediator of firm adhesion of leukocytes is intercellular adhesion molecule (ICAM)-1. It plays an important role in the regulation of adhesion and migration of all types of inflammatory cells.13
Expression of leukocyte adhesion molecules is mediated by a number of
endothelial and leukocyte activators. Cytokines such as interleukin
(IL)-1 and tumor necrosis factor (TNF)-
are one class of endothelial
activators. Bacterial components such as Gram-negative bacterial
lipopolysaccharide (LPS) also are able to induce the expression of
adhesion molecules. Little published information is available regarding
Gram-positive bacterial components and their ability to activate
endothelial cells and initiate inflammatory cell
migration.14
15
16
17
18
The mechanisms of leukocyte infiltration into the eye during bacterial
endophthalmitis are not well understood. Bacteria can actively grow in
the vitreous and produce extracellular products that presumably
interact with ocular tissues. The primary goal of these studies was to
determine the type and time course of adhesion molecule expression
after S. aureus injection in an established rat model of
bacterial endophthalmitis.19
Our secondary objective was
to investigate the contribution of bacterial components such as cell
wall (CW), its components ribitol teichoic acid (RTA) and peptidoglycan
(PG), and the secreted product
-hemolysin to the induction of
adhesion molecule expression on vascular endothelial cells in culture.
Specifically, we examined the in vivo expression of E-selectin and
ICAM-1 in ocular tissues after injection of S. aureus and
the in vitro expression of adhesion molecules after stimulation with
S. aureus components.
| Methods |
|---|
|
|
|---|
-, ß-, and
-hemolysin; lipases;
and fibronectin-binding protein.20
The WT and a mutant
strain of the WT S. aureus strain, deficient in the
production of hemolysins and lipase,20
were used in our in
vitro studies. Both strains of S. aureus were gifts from
Ambrose Cheung, Rockefeller University, New York, New York. Isolates
were maintained in sheep blood at -70°C. In preparation for use,
bacteria were plated onto rabbit or sheep blood agar plates and
incubated at 37°C for 24 hours. A discrete colony was subcultured
into sterile tryptic soy broth (Sigma, St. Louis, MO) and incubated in
a shaking water bath at 37°C for 18 hours. The bacterial culture was
centrifuged at 1900g for 10 minutes and the pellet washed
with 0.85% LPS-free sterile saline (NS) and centrifuged, and the
resultant pellet was resuspended in NS. A dilution was made to a
spectrophotometric optical density (Spectronic 21; Bausch and Lomb,
Rochester, NY) of 0.19 to 0.20 at 530 nm, which corresponded to a
viable bacterial count of approximately 1.5 x
108 colony-forming units (CFU) per milliliter.
This suspension of S. aureus was adjusted by serial dilution
with NS to yield a final concentration of approximately 80 CFU per 25
µl for intravitreal injection. S. aureus was heat-killed
by heating the final concentration at 80°C for 30 minutes.
Purified S. aureus RTA was purchased from Meridian
Diagnostics (Cincinnati, OH) and S. aureus
-hemolysin was
purchased from Toxin Technology (Sarasota, FL). CW was purified from an
ocular isolate of S. aureus by a previously described
method.21
Ribitol teichoic acid,
-hemolysin, and CW
were tested for the presence of LPS with the limulus amebocyte lysate
assay and were found to be below detectable limits (0.002 µg/µl).
Intravitreal Injections
Twenty-seven female Lewis rats, 8 to 10 weeks old (Harlan
SpragueDawley, San Diego, CA) raised in a pathogen-free environment
were used in this study. Studies were conducted in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research. Under direct observation, the right eye of each experimental
rat received a 25-µl intravitreal injection of either S.
aureus or NS, following a procedure previously
described.19
Before the intravitreal injection,
paracentesis was performed 1 mm anterior to the limbus to limit
extrusion of the inoculum. Additionally, 25 µl of the S.
aureus suspension was plated onto rabbit and sheep blood agar
plates and incubated at 37°C for 24 hours to confirm the approximate
number of S. aureus injected into the eye. Rats were killed
6, 24, 48, and 72 hours after injections.
In Vivo Adhesion Molecule Expression
Eyes were sectioned on a cryostat (ReichertJung 2800 Frigocut E;
Leica, Deerfield, IL) at 6 to 8 µm and stored at -70°C. For both
ICAM-1 and E-selectin staining, tissue sections were air dried and
fixed in ice-cold 95% methanol for 5 minutes. After fixation, sections
were washed with 1x phosphate-buffered saline (PBS, pH 7.4).
Endogenous peroxidase was blocked for 20 minutes at room temperature
(RT) with 0.6% hydrogen peroxide. For E-selectin detection, an
avidin-biotin block (Vector, Burlingame, CA) was performed followed by
a wash with PBS. Tissue sections in the E-selectin and ICAM-1 groups
were then blocked with PBS containing 10% horse serum (Gibco, Grand
Island, NY) and 1% bovine serum albumin (BSA; Sigma) for 1 hour at RT.
For ICAM-1, mouse anti-rat ICAM antibody (Ab; clone 1A29), 1 to 5
µg/ml (Serotec, Raleigh, NC) and for E-selectin, mouse anti-rabbit
E-selectin, 1 µg/ml (monoclonal [m]Ab 14G2, a gift from Barry A.
Wolitsky, HoffmanLaRoche, Nutley, New Jersey), which cross-reacts
with rat E-selectin22
were applied to the tissue. Control
tissues were incubated with a mouse immunoglobulin (Ig)G isotype
control Ab (Dako, Carpinteria, CA) overnight at 4°C. After incubation
with primary Ab, a biotinylated horse anti-mouse IgG (1 µg/ml;
Vector) was applied to the tissue and incubated at RT for 30 minutes.
E-selectin and ICAM-1 were detected using the avidin-biotin complex
(Vector). ICAM-1 was developed with 3-amino-9-ethylcarbazole (Sigma)
producing red staining and E-selectin was developed with
3,3'-diaminobenzidine tetrahydrochloride (Sigma) producing brown
staining. Tissues were counter-stained with hematoxylin (Biømeda,
Foster City, CA).
The intensity of staining in the iris, ciliary body (CB), retina, and choroid, and the approximate area of tissue stained per section were scored on a scale of 0 (absent) to 3 (strong) by two observers in a masked fashion. Random sections from noninjected, NS and S. aureusinjected eyes of three rats (n = 3) were stained in triplicate, and mean levels of staining intensity were calculated for each time point.
In Vitro Adhesion Molecule Assay
Aortic endothelial cells were obtained from human donor tissue
according to a previously described procedure.23
Fifth- to
eighth-passage cells were plated onto 96-well plates (Costar,
Cambridge, MA) and grown to confluence. Endothelial cells in Medium
1995% fetal bovine serum were stimulated with live S.
aureus strains, heat-killed S. aureus, CW, PG, RTA, and
-hemolysin. To detect expression of E-selectin, cells were washed
and immediately fixed with 1% paraformaldehyde (PF) on ice for 20
minutes. After fixation, cells were washed with 1x tris-buffered
saline (TBS)-5% glycine and then 1x PBS. Next, mouse anti-human
E-selectin mAb (Biosource, Camarillo, CA) was added (1 µg/ml) and
incubated overnight at 4°C. For ICAM, cells were incubated with a
mouse anti-human ICAM mAb (1 µg/ml; Biosource) on ice for 1 hour.
After incubation, cells were washed and fixed with 1% PF on ice for 20
minutes. After fixation, cells were washed with 1x TBS-5% glycine
then with 1x PBS-1% BSA. After incubation, a goat anti-mouse
horseradish peroxidaseconjugated secondary Ab (Jackson
ImmunoResearch, West Grove, PA) was added to the wells and incubated
for 2 hours at RT. Cells were washed, and adhesion molecule expression
was detected with o-phenylenediamine (Sigma). After 5
minutes, the reaction was stopped with 3 N hydrochloric acid, and the
plates were read at 490 nm with a microplate reader (Thermo-max,
Molecular Devices, Sunnyside, CA). Lipopolysaccharide (0.002 µg/ml)
served as the positive control in all experiments.
Statistical Analysis
For in vitro studies, each condition was tested in quadruplicate
and experiments were repeated two to three times. For whole-cell
enzyme-linked immunosorbent assays, analysis of variance with
FisherTukey least-significant difference criterion was used to
analyze the data (Statview; Abacus Concepts, Berkeley, CA).
Significance was determined at P < 0.05.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
-hemolysin did not induce expression of E-selectin or ICAM-1, nor
did heat-killed WT S. aureus at concentrations of 1.5 x 102 to 1.5 x 106
CFU. However, heat-killed S. aureus at a concentration of
1.5 x 108 CFU induced expression of
E-selectin (P < 0.01). Interestingly, heat-killed
Escherichia coli at concentrations of 1.5 x
104 and 1.5 x 106 CFU
induced expression of both E-selectin and ICAM-1 (data not shown). | Discussion |
|---|
|
|
|---|
Results from the present studies show that adhesion molecules were
expressed in ocular tissues after intravitreal injection of viable
S. aureus. Adhesion molecule expression precedes leukocyte
entry, as published in our previous model.24
Our in vivo
experiments showed that E-selectin expression peaked at 6 to 24 hours
in S. aureusinjected eyes, slowly declined, and returned
to constitutive levels at 72 hours. The rapid and sustained expression
of E-selectin in the iris, CB, and retinal vessels is similar to the in
vivo findings of Suzuma et al.42
in a rat model of
endotoxin-induced uveitis. In this model, E-selectin expression was not
detected in the iris, CB, or retina 5 hours after LPS injection but was
detectable in these structures after 7 hours. Expression remained
present in these tissues for 24 hours. Our findings also are comparable
with other in vivo reports in which E-selectin expression was
detectable on microvessels up to 72 hours after LPS injection in
cutaneous models of inflammation.43
The time course of
E-selectin expression seen in our model is similar to that seen in in
vitro studies of microvascular endothelial cells44
45
but
not large-vessel endothelial cells in which E-selectin is rapidly
induced and rapidly decreased.46
In vitro studies have
demonstrated that dermal microvascular endothelial cells show a peak
E-selectin expression at 6 to 8 hours and sustained expression after
treatment with TNF.44
In contrast to E-selectin, in vitro
ICAM-1 expression peaks between 16 to 24 hours and persists at peak
levels as long as proinflammatory cytokines are present.47
Our in vivo ICAM-1 data are consistent with these findings.
Upregulation of ICAM-1 expression was first seen at 6 hours, with
maximal expression occurring at 24 hours followed by decreases in
staining intensities at 48 and 72 hours. The sustained in vivo
expression pattern of E-selectin and ICAM-1 seen in our model may be in
response to vitreous bacterial products and/or cytokines whose
production we have shown to be increased after injection of viable
S. aureus.25
In the present study, the 24-hour
peak in ICAM-1 expression corresponded to the peak levels of
intravitreal TNF-
, IL-1ß, cytokine-induced neutrophil
chemoattractant (CINC), and interferon-
.
Inflammatory cells can enter the eye from the CB, iris, choroid, and
retinal vasculature. Our previous study24
showed that most
inflammatory cells entered the eye from the CB and iris, with fewer
entering from the choroid and retina. The in vivo data presented in
this study support this finding, because the CB and iris tissues
demonstrated the most widespread and intense E-selectin and ICAM-1
staining pattern. This agrees with Bamforth et al.,48
who
showed that the origin of leukocytes in the vitreous, after
intravitreal IL-1ß injection, was thought to be derived from the CB.
Vessels of the CB are fenestrated and are not part of the
bloodretinal barrier. Therefore, they may demonstrate an adhesion
molecule expression and leukocyte transmigration pattern similar to
that seen in other postcapillary endothelial cells but different from
vessels that are part of the bloodretinal barrier. In our past
work24
and this present study, there was a small but
significant increase in inflammatory cells and adhesion molecule
expression associated with the retinal vessels of the optic nerve,
suggesting that retinal vessels may be a source of vitreous cells.
Bamforth et al.,48
have shown that leukocyte infiltration
into the retina occurs from the retinal vasculature and that leukocytes
may migrate through retinal vessel tight junctions or through the
endothelial cell itself in response to intravitreal IL-1ß injection.
These same investigators have also shown that intravitreal injection of
IL-1ß and TNF-
lead to increased permeability of the
bloodretinal barrier and infiltration of inflammatory
cells.49
50
The different staining intensities between the
CB and retinal vessels may be due to different endothelial responses to
host factors, Gram-positive bacteria and/or components. In vitro
studies have shown that lymphocyte adhesion to brain and retinal
endothelial cells differs from lymphocyte adhesion to endothelial cells
of noncentral nervous system origin.51
In vitro cell culture assays were used to determine whether S. aureus components may be responsible for induction of the adhesion molecules detected in ocular tissues. In our in vivo studies there were increases in both E-selectin and ICAM-1 expression at 6 hours; therefore, we chose to investigate the early induction phases of the response in vitro. To the best of our knowledge, this is the first report to demonstrate the ability of S. aureus RTA and PG to induce the in vitro expression of E-selectin and ICAM-1 on human aortic endothelial cells. In our studies, RTA generally was not as effective as PG and LPS in inducing E-selectin and ICAM-1 expression. Lower concentrations of PG induced the expression of adhesion molecules, but the concentration of PG needed to induce expression of E-selectin and ICAM-1 was still five times (0.01 µg/ml) greater than the minimal LPS concentration required for adhesion molecule expression (0.002 µg/ml). In studies by other investigators, it also has been demonstrated that greater concentrations of PG are needed to induce the production of cytokines from monocytes compared with LPS.52 53 Interestingly, studies have shown that when PG is bound to lipoteichoic acid (LTA) it is a more potent stimulator of IL-1 than is LPS54 and is associated with systemic inflammation.55
We were unable to detect expression of adhesion molecules after
stimulation with S. aureus CW. The CW is composed of
many products, including PG and RTA covalently linked. The inability of
CW to induce expression may be because the CW preparation was not
fragmented enough to allow exposure of the activating determinants. The
concentrations of PG and RTA used in our study are consistent with
those used in Kawamura et al.15
who showed that S.
aureus LTA induces the in vitro expression of E-selectin,
ICAM-1, and VCAM. In their study, maximum E-selectin expression
occurred with a LTA concentration of 10 µg/ml, which was 100 times
greater than the amount of LPS needed to induce maximal E-selectin
expression. The receptors for PG and RTA are not known, but it has been
shown that a soluble form of PG binds to CD14 on monocytes inducing the
release of IL-6.56
Additionally, we were unable to
demonstrate consistent expression of E-selectin and ICAM-1 after
stimulation with
-hemolysin. We used concentrations as low as 0.001
µg/ml and did not observe any loss of endothelial cells (data not
shown).
In our in vitro system, heat-killed S. aureus at concentrations of 1.5 x 106 CFU/ml and less were unable to stimulate the expression of E-selectin and ICAM-1, but heat-killed E. coli induced expression of these molecules. The inability of heat-killed S. aureus to induce expression of adhesion molecules is consistent with our data showing that purified CW did not induce adhesion molecule expression. This finding is also consistent with a report by Noel et al.16 in which heat-killed S. aureus failed to induce expression of E-selectin. Heat killing may alter the structure of the CW and the PGRTA complex making it unable to directly activate endothelial cells to express adhesion molecules. Alternately, the component(s) responsible for activation of endothelial cells may be buried in the CW of S. aureus, whereas in E. coli the LPS molecules may be exposed on the outer aspect of the cell membrane, thus allowing for activation. We used macrovascular endothelial cells to evaluate responses to S. aureus and its components in vitro. The relevance of these findings to microvascular endothelial cells must be determined in future studies. However, the kinetics of induction of adhesion molecules in our in vitro studies were quite similar to the in vivo findings.
In summary, our studies have suggested a role for E-selectin and ICAM-1 in leukocyte entry in S. aureus endophthalmitis. In addition, we have shown that Gram-positive bacterial products are able to induce the in vitro expression of E-selectin and ICAM-1. Our previous studies also suggested a role for cytokines in this process. Therefore, adhesion molecule expression by ocular tissues may be mediated directly by bacterial products or through intermediates such as cytokines. To achieve activation of the basal aspect of the endothelial cells in the iris, CB, and retinal vessels, bacterial products would have to diffuse through the vitreous, retina, and CB. This activation would result in the subsequent expression of adhesion molecules followed by the infiltration of leukocytes. Thus, our studies suggest that a combination of bacterial and host factors regulate the early stages of endophthalmitis and consequently may serve as therapeutic targets.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication January 21, 1999; revised April 14 and July 6, 1999; accepted August 17, 1999.
Commercial relationships policy: N.
Corresponding author: Michael J. Giese, Jules Stein Eye Institute, 100 Stein Plaza, DSERC 3-143, UCLA School of Medicine, Los Angeles, CA 90095-7000. mgiese{at}ucla.edu
| References |
|---|
|
|
|---|
-toxin potently induce neutrophil adhesion to cultured human endothelial cells J Immunol 157,4133-4140[Abstract]
and IL-6 on the permeability of the rat bloodretinal barrier in vivo Acta Neuropathol 91,624-632[Medline][Order article via Infotrieve]
This article has been cited by other articles:
![]() |
M. J. Giese, S. A. Rayner, B. Fardin, H. L. Sumner, N. Rozengurt, B. J. Mondino, and L. K. Gordon Mitigation of Neutrophil Infiltration in a Rat Model of Early Staphylococcus aureus Endophthalmitis Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3077 - 3082. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Jorgensen, J. E. Wang, M. Almlof, C. Thiemermann, S. J. Foster, R. Solberg, and A. O. Aasen Peptidoglycan and Lipoteichoic Acid Modify Monocyte Phenotype in Human Whole Blood Clin. Vaccine Immunol., May 1, 2001; 8(3): 515 - 521. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |